Hospira’s Proprietary Rights. Hospira has granted no license, express or implied, to Theravance to use Hospira proprietary technology, know-how or other proprietary rights: (a) existing as of the Effective Date; or (b) developed by or for Hospira on or after the Effective Date outside the scope of any Project undertaken by Hospira pursuant to this Agreement.
Hospira’s Proprietary Rights. Except as otherwise provided in this Article 9, Hospira has granted no license, express or implied, under this Agreement to Cempra to use Hospira Intellectual Property for the development, manufacture and supply of the Product.
Hospira’s Proprietary Rights. Hospira has granted no license, express or implied, to Theratechnologies to use Hospira proprietary technology, know-how or other proprietary rights other than for the purposes of this Agreement.
Hospira’s Proprietary Rights. Hospira has granted no license, express or implied, to Abbott to use Hospira's proprietary technology, know-how or rights relating to the Products, other than for the purposes of this Agreement. If Hospira, in its sole discretion, deems patentable any improvement or invention related to the Products or to Hospira's proprietary technology, know-how or rights relating to the Products, then Hospira shall solely own and shall be entitled to apply for patent protection on such improvements or inventions at its expense and risk.
Hospira’s Proprietary Rights. Except for the purposes of this Master Agreement and/or relating to the Products and Services hereunder, Hospira has granted no license, express or implied, to Genzyme to use Hospira’s proprietary technology, know-how or other proprietary rights (i) existing as of the Effective Date; or (ii) developed by or for Hospira on or after the Effective Date. It is understood and agreed by the Parties that Genzyme shall owe no further fees, payments or royalties of any kind on any Product Manufactured by Hospira (except as [**] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. expressly detailed in the applicable Project SOW), regardless of the technology, know-how or other proprietary processes used by Hospira in the Manufacture of Products or the performance of Services hereunder.
Hospira’s Proprietary Rights. Hospira has granted no license, express or implied, to Hologic to use Hospira proprietary technology, know-how or other proprietary rights (i) existing as of the Effective Date, or (ii) developed by or for Hospira on or after the Effective Date outside the scope of any Project undertaken by Hospira pursuant to this Agreement. Hospira shall be the sole owner of any proprietary technology, know-how or other proprietary rights developed by or for Hospira pursuant to any Project undertaken by Hospira (the “Project Inventions”). However, Hospira shall grant to Hologic, and does hereby grant to Hologic, an exclusive (even as to Hospira), royalty-free, paid up, worldwide, perpetual license under such Project Inventions to make, have made, use, offer for sale, sell, and/or import Drug and Product. [***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
Hospira’s Proprietary Rights. Hospira has granted no license, express or implied, to Company to use Hospira proprietary technology, know-how or other proprietary rights (i) existing as of the Effective Date, or (ii) developed by or for Hospira on or after the Effective Date outside the scope of the Project. Hospira shall be the sole owner of any proprietary technology, know-how or other proprietary rights developed by or for Hospira pursuant to the Project undertaken by Hospira, including the supply of Product hereunder ("Hospira Project Intellectual Property"). However, Hospira shall grant to Company, and does hereby grant to Company, an exclusive (even as to Hospira), royalty-free, paid up, worldwide, perpetual license in the Field under Hospira Project Intellectual Property such Project inventions to make, have made, use, offer for sale, sell and/or import products. Hospira covenants that, other than for purposes of this Agreement, it will not use or license Hospira Project Intellectual Property to make, have made, use, offer for sale, sell or import any product in the Field.
Hospira’s Proprietary Rights. Hospira has granted no license, express or implied, to Genzyme to use Hospira’s proprietary technology, know-how or other proprietary rights: (i) existing as of the Effective Date other than for the purposes of this Agreement; or (ii) developed by or for Hospira on or after the Effective Date other than for the purposes of this Agreement. Genzyme has granted no license, express or implied, to Hospira to use Genzyme’s proprietary technology, know-how or other proprietary rights other than for the purposes of this Agreement. Notwithstanding Hospira’s rights, the Parties agree that Genzyme shall be the sole owner of any proprietary technology, know-how or other proprietary rights developed by or for Hospira pursuant to any Project undertaken by Hospira (the “Project Inventions”). Hospira shall notify Genzyme of all Project Inventions and shall use all reasonable efforts to cooperate with Genzyme in any related patent filing and prosecution (each at Genzyme’s expense) and shall assign all right, title and interest in any such Project Inventions to Genzyme.
Hospira’s Proprietary Rights. Hospira has granted no license, express or implied, to Kythera to use Hospira proprietary technology, know-how or other proprietary rights: (a) existing as of the Effective Date; or (b) developed by or for Hospira on or after the Effective Date outside the scope of any Project undertaken by Hospira pursuant to this Agreement.
Hospira’s Proprietary Rights. Hospira has granted no license, express or implied, to OBI to use Hospira proprietary technology, know-how or rights relating to its manufacturing processes. If Hospira, in its sole discretion, deems patentable any improvement or invention related to Hospira’s proprietary technology, know-how or rights relating to diluent solutions, glass or non-glass vials, cartridges, formulations of diluent or intravenous solutions or manufacturing processes made or reduced to practice in the course of performance of the development activities under the Project, then Hospira shall solely own and shall be entitled to apply for patent protection on such improvements or inventions at Hospira’s expense and risk.
